• Home
  • Contact Us
  • Try it!
  • Graphs
  • Publications
  • Blog

Follow us

Recent Posts

  • Biovista Vizit New Corpus: ClinicalTrials.gov September 16, 2025
  • Biovista Vizit New Corpus: MATISSE (a SoftMining algorithm) May 13, 2025
  • Biovista Vizit New Corpus: HPO March 4, 2025
  • Biovista Vizit January 2025 Release – AOP Features January 30, 2025
  • Uberon OBO Contribution May 22, 2024

Biovista Vizit

Biovista Vizit

  • Try it!
  • Graphs
  • Publications
  • Blog

Mechanistic analysis of Tocilizumab

June 19, 2020COVID-19, Vizit Graphs
Mechanistic analysis of TocilizumabEftychia Lekka2020-08-18T07:45:39-04:00
Mechanistic analysis of Tocilizumab

Tocilizumab (Acterma) is an immunosuppressive drug (IL-6 inhibitor) mainly used in the treatment of rheumatoid arthritis and is currently being tested in COVID-19 patients.

Explore the live graph.

Tags: ACE, ACE2, ALBUMIN, ANGIOTENSIN II, APOE, BLOOD VESSEL DISEASE, COVID-19, FIBRINOGEN, HEMOGLOBIN, ICAM1, IL1B, IL6, LACTATE DEHYDROGENASE, NFKB1, RAS, SARS-COV-2, THROMBIN, TNF, VEGFA

Post navigation

← Mechanistic analysis of Ivermectin
Mechanistic analysis of Azithromycin →
TMPRSS2 TISSUE DEVELOPMENT VEGFA THROMBIN VASOCONSTRICTION TREPONEMA DENTICOLA VGF PROTEIN VASODILATION TIMELESS TGF-BETA Uberon TAU VEGF TYPE 2 DIABETES VITAMIN D THORAX UBIQUITINATION VEINS TRASTUZUMAB TROPISM TH17 CELLS WOUND HEALING THROMBOCYTOPENIA VIRUS DISEASES VERO CELLS TAUOPATHIES TECFIDERA UCHL1 PROTEIN ULCERATIVE COLITIS X-RAY COMPUTED TOMOGRAPHY TUMOR PROGRESSION TARGET LESION IDENTIFICATION TP53 TRACHEA TUMOR TRANSPORT TRANSLATION TROGLITAZONE THY-1 ANTIGENS TUMOR GROWTH VIRAL RELEASE FROM HOST CELL VASCULAR THROMBOSIS

© 2026 Biovista Vizit All Rights Reserved.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}